195 results
Page 3 of 10
6-K
e4yogm4nahxbh7sjo
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
ngl 6p1b1zgv74arnpv3
8 Dec 22
Current report (foreign)
6:46am
6-K
EX-99.1
i1yj4fak
30 Nov 22
Current report (foreign)
6:28am
6-K
93aru6
4 Nov 22
Current report (foreign)
6:01am
6-K
EX-99.1
ubsmokoejpg yuzu3
27 Oct 22
Current report (foreign)
6:01am
6-K
h1qbl95a
14 Oct 22
Current report (foreign)
7:36am
6-K
43y hi9oiajjuy4
4 Oct 22
Current report (foreign)
6:06am
6-K
EX-99.1
g97lx1mzyh6a2
23 Aug 22
Current report (foreign)
6:13am
6-K
EX-99.1
obgwi fqrv03u
4 Aug 22
Current report (foreign)
6:07am
6-K
wgidyh
4 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.1
sytsz0 zay5fon3xxeu6
28 Jul 22
Current report (foreign)
6:09am
6-K
uwnq8ipl4zgfbs51lbj
11 Jul 22
Current report (foreign)
6:05am
6-K
9gxq6r 8quj
29 Jun 22
Current report (foreign)
6:02am
6-K
azeqx5 5iqqswb
31 May 22
Current report (foreign)
6:20am
6-K
odiik1p
31 May 22
Current report (foreign)
6:18am
6-K
EX-99.1
cnnoi7o zhuv
31 May 22
Current report (foreign)
6:14am
6-K
EX-99.1
oieius
31 May 22
Current report (foreign)
6:07am
6-K
EX-99.1
mrm7ac86w jclhxay
31 May 22
Current report (foreign)
12:00am
6-K
yyvttxkv49isabb5hg8i
11 May 22
Current report (foreign)
6:11am